@ARTICLE{
author={Van Cutsem Eric,Hidalgo Manuel,Bazin Igor,Canon Jean-Luc,Poddubskaya Elena,Manojlovic Nebojsa S,Milella Michele,Radenkovic Dejan V,Verslype Chris,Guo Wei,Damstrup Lars,Hammel Pascal},
year={2015},
title={Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={33},
number={3},
pages={-},
document_type={Meeting Abstract},
}